Capitol Health (CAJ) Stock Price, News & Analysis

Company Overview

Capitol Health Limited provides diagnostic imaging modalities and related services to the healthcare market in Australia. It offers a range of diagnostic imaging services, including general x-ray, magnetic resonance imaging, ultrasound, mammography, Doppler, orthopantomogram, echocardiography, computed tomography, CT angiography, cone beam CT, nuclear medicine, bone densitometry, and fluoroscopy. It operated various clinics in Victoria, Tasmania, Western Australia, and South Australia under the Capital Radiology brand, as well as under the Imaging Olympic Park, Radiology Tasmania, Fowler Simmons Radiology, Womens' Imaging, Direct Radiology, and Future Medical Imaging Group brand names. The company was incorporated in 2005 and is headquartered in East Melbourne, Australia.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 803,795 shs
• Average Volume: N/A
• Market Capitalization: A$413.13 million
• P/E Ratio: N/A
• Dividend Yield: 2.33%
• Price Target: N/A
• Consensus Rating: N/A

CAJ Stock Analysis - Frequently Asked Questions

How were Capitol Health's earnings last quarter?

Capitol Health Limited (ASX:CAJ) issued its earnings results on Wednesday, February, 27th. The company reported $0.02 EPS for the quarter. Capitol Health had a negative net margin of 6.33% and a negative trailing twelve-month return on equity of 12.14%.

What other stocks do shareholders of Capitol Health own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Capitol Health investors own include Paragon Care (PGC), South32 (S32), McMillan Shakespeare (MMS) and G8 Education (GEM).

Company Calendar

• Last Earnings: 2/27/2019
• Today: 10/10/2025

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: Medical
• Industry: Medical Care Facilities
• Sub-Industry: N/A
• Current Symbol: ASX:CAJ
• CIK: N/A
• Web: www.capitolhealth.com.au
• Phone: +61-3-93483333
• Fax: N/A
• Employees: 1,000
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): A($0.01)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: 0.41
• Net Income: -A$14.85 million
• Net Margins: -6.33%
• Pretax Margin: N/A
• Return on Equity: -12.14%
• Return on Assets: 4.32%

Debt

• Debt-to-Equity Ratio: 74.66
• Current Ratio: 0.44
• Quick Ratio: 0.58

Sales & Book Value

• Annual Sales: A$234.82 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 25.71
• Book Value: A$0.10 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 1,070,000,000
• Free Float: N/A
• Market Cap: A$413.13 million
• Optionable: Not Optionable
• Beta: 0.65